syndrome	score	normalized_score
PERIPHERAL CONE DYSTROPHY	1.33694311	100.0
RETINITIS PIGMENTOSA 18	1.166667	87.263772951416
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.0117202500000002	75.67414368140169
MOWAT-WILSON SYNDROME; MOWS	1.00121359	74.88827179789274
MEVALONIC ACIDURIA; MEVA	1.00121359	74.88827179789274
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.0	74.7974983019285
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	1.0	74.7974983019285
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	1.0	74.7974983019285
Leber congenital amaurosis 17	1.0	74.7974983019285
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.6801781	50.87562027975895
CONE-ROD DYSTROPHY 8; CORD8	0.60990099	45.61906826386951
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.5555556	41.55416904762687
#616152 MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5	0.5434783	40.65081722138498
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.5140845	38.45223451579776
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.5140845	38.45223451579776
#165550 OPTIC NERVE HYPOPLASIA, BILATERALOPTIC NERVE APLASIA, BILATERAL, INCLUDED	0.51306939	38.37630682729649
BOHRING-OPITZ SYNDROME	0.50121359	37.489522646928485
#177700 GLAUCOMA 1, OPEN ANGLE, P; GLC1P	0.5	37.39874915096425
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.5	37.39874915096425
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.5	37.39874915096425
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5	37.39874915096425
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.5	37.39874915096425
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	0.5	37.39874915096425
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.38731796	28.970414455406413
OPTIC ATROPHY 1; OPA1	0.38731796	28.970414455406413
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.378811	28.334115129251835
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.37179449999999997	27.80929848241635
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.35448701	26.51474152853071
OPTIC ATROPHY 9; OPA9	0.34383966	25.71834638498567
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.333333	24.932474501476733
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.333333	24.932474501476733
OPTIC ATROPHY 5; OPA5	0.29708841	22.221469842497637
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.29708841	22.221469842497637
CATARACT 7; CTRCT7	0.2675439	20.011614405941327
RETINOSCHISIS OF FOVEA	0.2675439	20.011614405941327
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.26306939	19.676932251814367
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.25689655	19.21521926239629
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.25361011	18.9694017720769
TUFTSIN DEFICIENCY	0.25	18.699374575482125
CONE-ROD DYSTROPHY 11; CORD11	0.25	18.699374575482125
#613587 OCCULT MACULAR DYSTROPHY; OCMD;;OMD	0.25	18.699374575482125
CEROID STORAGE DISEASE	0.25	18.699374575482125
CEPHALIN LIPIDOSIS	0.25	18.699374575482125
LATE-ONSET RETINAL DEGENERATION; LORD	0.19411189	14.519083762659132
RETINITIS PIGMENTOSA 58	0.1909091	14.279523083072698
CONE-ROD DYSTROPHY 2	0.18353164	13.727707531250152
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.17717366	13.252146532996456
RETINAL CONE DYSTROPHY 3B	0.166667	12.466274649487517
#607476 NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD	0.166667	12.466274649487517
SENIOR-LOKEN SYNDROME 3	0.16040089999999999	11.997586045377801
#613341 LEBER CONGENITAL AMAUROSIS 14; LCA14RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	0.14975354999999999	11.201190901832762
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.14646710999999998	10.955373411513373
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.14285699999999998	10.685346214918598
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.14285699999999998	10.685346214918598
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.14285699999999998	10.685346214918598
JOUBERT SYNDROME 5	0.14285699999999998	10.685346214918598
CONE-ROD DYSTROPHY 10	0.1222222	9.141914796957964
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.11728383999999999	8.772537823243653
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.11728383999999999	8.772537823243653
SENIOR-LOKEN SYNDROME 4; SLSN4	0.1172249	8.768129258693738
Yao syndrome	0.11590910000000001	8.669710710428062
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.11551629	8.640329505120079
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.11472110999999999	8.58085203042035
CLUSTER HEADACHE, FAMILIAL	0.11111099999999999	8.310824833825576
#615040 EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1	0.11111099999999999	8.310824833825576
BUERGER DISEASE	0.11111099999999999	8.310824833825576
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.11111099999999999	8.310824833825576
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.11111099999999999	8.310824833825576
CONE-ROD DYSTROPHY 6; CORD6	0.10689655	7.995594517107015
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.1044202	7.810369732187033
Retinitis pigmentosa with or without skeletal anomalies	0.10121359	7.570523326157088
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.10081009	7.540342535592259
RETINITIS PIGMENTOSA 75; RP75	0.1	7.47974983019285
RETINITIS PIGMENTOSA 41	0.1	7.47974983019285
#613810 RETINITIS PIGMENTOSA 43; RP43	0.1	7.47974983019285
#613767 RETINITIS PIGMENTOSA 45; RP45	0.1	7.47974983019285
RETINITIS PIGMENTOSA 20	0.09708194	7.261486242297925
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.09451921	7.069800449474624
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0909091	6.799773252879849
#262300 ACHROMATOPSIA 3; ACHM3;;PINGELAPESE BLINDNESS;;TOTAL COLORBLINDNESS WITH MYOPIA;;ACHROMATOPSIA WITH MYOPIA;;ACHM1, FORMERLY;;ROD MONOCHROMATISM 1, FORMERLY;;ROD MONOCHROMACY 1, FORMERLY; RMCH1, FORMERLY	0.0909091	6.799773252879849
ALAND ISLAND EYE DISEASE	0.0909091	6.799773252879849
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0909091	6.799773252879849
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.0909091	6.799773252879849
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.0909091	6.799773252879849
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.0909091	6.799773252879849
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	0.0909091	6.799773252879849
#613826 LEBER CONGENITAL AMAUROSIS 6; LCA6	0.0909091	6.799773252879849
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	0.0909091	6.799773252879849
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.0909091	6.799773252879849
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	0.0909091	6.799773252879849
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0909091	6.799773252879849
GLUTAMATE MONOSODIUM SENSITIVITY	0.0909091	6.799773252879849
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	0.0909091	6.799773252879849
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.08187140000000001	6.12377590247651
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.08014676000000001	5.994777145005072
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.07724076	5.777415614939667
ALSTROM SYNDROME; ALMS	0.07691428	5.752995727694053
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.07670961000000001	5.7376869237165975
#615233 RETINITIS PIGMENTOSA 66; RP66	0.07363065	5.507388418344892
CONE-ROD DYSTROPHY 20; CORD20	0.07363065	5.507388418344892
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.06606226	4.941291780171558
RETINITIS PIGMENTOSA 4; RP4	0.06545659000000001	4.8959891793750305
OPTIC ATROPHY 8	0.06463231000000001	4.8343350974747175
USHER SYNDROME, TYPE IIIA	0.062452150000000005	4.671264583576784
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.062452150000000005	4.671264583576784
RETINITIS PIGMENTOSA 78; RP78	0.062452150000000005	4.671264583576784
CAVITARY OPTIC DISC ANOMALIES; CODA	0.062452150000000005	4.671264583576784
PREPAPILLARY VASCULAR LOOPS	0.0611888	4.576769164097042
#604116 CONE-ROD DYSTROPHY 3; CORD3	0.061022200000000006	4.564307900879942
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.05916571	4.425447093257394
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0588697	4.40330628578504
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.05746359	4.298132775447716
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.056122500000000006	4.197822598449982
INFANTILE SIALIC ACID STORAGE DISEASE	0.056063489999999994	4.193408798075185
#609923 RETINITIS PIGMENTOSA 31; RP31	0.055555600000000004	4.155419896662619
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.055555600000000004	4.155419896662619
CRANIOSYNOSTOSIS 2	0.055555600000000004	4.155419896662619
#615725 RETINITIS PIGMENTOSA 68; RP68	0.055555600000000004	4.155419896662619
RETINITIS PIGMENTOSA 62; RP62	0.055555600000000004	4.155419896662619
#613809 RETINITIS PIGMENTOSA 39; RP39	0.055555600000000004	4.155419896662619
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.055555600000000004	4.155419896662619
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.053984960000000005	4.037939953929678
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0533617	3.9913216651380172
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.05040969	3.7705187021757416
MACULAR DYSTROPHY, RETINAL, 2	0.050374850000000006	3.7679127573349027
CONE-ROD DYSTROPHY, X-LINKED, 3	0.050374850000000006	3.7679127573349027
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.050374850000000006	3.7679127573349027
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.050374850000000006	3.7679127573349027
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.050374850000000006	3.7679127573349027
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.050374850000000006	3.7679127573349027
ACHROMATOPSIA 7; ACHM7	0.050374850000000006	3.7679127573349027
CONE-ROD DYSTROPHY 17; CORD17	0.04965114	3.7137810598388143
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.04824928	3.6089254388692726
MUCOLIPIDOSIS IV; ML4	0.04549725	3.4030804796174166
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.045478000000000005	3.4016406277751043
#303100 CHOROIDEREMIA; CHM;;TAPETOCHOROIDAL DYSTROPHY, PROGRESSIVE; TCDCHOROIDAL SCLEROSIS, INCLUDED	0.045478000000000005	3.4016406277751043
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.045224	3.382642063206414
SCLEROSTEOSIS 1; SOST1	0.04440981	3.3217426880639676
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.043478300000000004	3.252068070420738
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.043478300000000004	3.252068070420738
CONE-ROD DYSTROPHY 18	0.043478300000000004	3.252068070420738
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0423351	3.166559570361973
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.04115099	3.0779911046476762
#604232 LEBER CONGENITAL AMAUROSIS 3; LCA3RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED, INCLUDED	0.0407997	3.051715491469192
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.040119590000000004	3.0008449648990676
COACH SYNDROME	0.040119590000000004	3.0008449648990676
RETINITIS PIGMENTOSA 11	0.04005334	2.9958896306365648
POTOCKI-LUPSKI SYNDROME	0.03967509	2.9675974769038604
WATSON SYNDROME	0.03967509	2.9675974769038604
THUMB DEFORMITY	0.0384615	2.876823980939623
SILVER-RUSSELL SYNDROME; SRS	0.0384615	2.876823980939623
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	2.876823980939623
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0384615	2.876823980939623
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	2.876823980939623
ACRORENAL-MANDIBULAR SYNDROME	0.0384615	2.876823980939623
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	2.876823980939623
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	2.876823980939623
ATROPHODERMA VERMICULATA; AVA	0.0384615	2.876823980939623
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	2.876823980939623
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	2.876823980939623
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	2.876823980939623
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	2.876823980939623
COWDEN SYNDROME 6; CWS6	0.0384615	2.876823980939623
BETHLEM MYOPATHY 1	0.0384615	2.876823980939623
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	2.876823980939623
HYPOADRENOCORTICISM, FAMILIAL	0.0384615	2.876823980939623
MUSCULAR HYPERTONIA, LETHAL	0.0384615	2.876823980939623
ARTERIES, ANOMALIES OF	0.0384615	2.876823980939623
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	2.876823980939623
COWDEN SYNDROME 5; CWS5	0.0384615	2.876823980939623
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.036927890000000005	2.7621137895688026
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.036927890000000005	2.7621137895688026
RETINAL CONE DYSTROPHY 4	0.03632519	2.71703333734223
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0357333	2.6727614460723017
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.0357333	2.6727614460723017
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0357333	2.6727614460723017
TERATOMA, PINEAL	0.035714300000000004	2.671340293604565
BLUE DIAPER SYNDROME	0.035714300000000004	2.671340293604565
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	2.671340293604565
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	2.671340293604565
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.035714300000000004	2.671340293604565
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.035714300000000004	2.671340293604565
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	2.671340293604565
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	2.671340293604565
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	2.671340293604565
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.035714300000000004	2.671340293604565
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.035714300000000004	2.671340293604565
GALLBLADDER, AGENESIS OF	0.035714300000000004	2.671340293604565
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	2.671340293604565
GASTRIC SNEEZING	0.035714300000000004	2.671340293604565
METHANE PRODUCTION	0.035714300000000004	2.671340293604565
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	2.671340293604565
219400 CYANOSIS AND HEPATIC DISEASE	0.035714300000000004	2.671340293604565
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	2.671340293604565
PARANA HARD-SKIN SYNDROME	0.035714300000000004	2.671340293604565
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	2.671340293604565
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.035714300000000004	2.671340293604565
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.035714300000000004	2.671340293604565
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.03523851	2.6357523918874906
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.03486011	2.6074490185300405
NAVAJO NEUROHEPATOPATHY	0.034546890000000004	2.584020946111911
TRICHOHEPATOENTERIC SYNDROME 1	0.034546890000000004	2.584020946111911
SMITH-MAGENIS SYNDROME; SMS	0.034546890000000004	2.584020946111911
RHEUMATOID ARTHRITIS	0.0333333	2.4932474501476736
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	2.4932474501476736
Growth hormone deficiency, isolated, type IA	0.0333333	2.4932474501476736
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	2.4932474501476736
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	2.4932474501476736
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	2.4932474501476736
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	2.4932474501476736
MYASTHENIA GRAVIS; MG	0.0333333	2.4932474501476736
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	2.4932474501476736
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0333333	2.4932474501476736
MYELOPEROXIDASE DEFICIENCY	0.0333333	2.4932474501476736
BLOOD GROUP, DUFFY SYSTEM; FY	0.0333333	2.4932474501476736
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0333333	2.4932474501476736
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.0333333	2.4932474501476736
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0333333	2.4932474501476736
SHORT SYNDROME	0.0333333	2.4932474501476736
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	2.4932474501476736
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	2.4932474501476736
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0333333	2.4932474501476736
IMMUNE SUPPRESSION	0.0333333	2.4932474501476736
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0333333	2.4932474501476736
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	2.4932474501476736
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	2.4932474501476736
ECHO VIRUS 11 SENSITIVITY	0.0333333	2.4932474501476736
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	2.4932474501476736
RAGWEED SENSITIVITY	0.0333333	2.4932474501476736
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	2.4932474501476736
BARDET-BIEDL SYNDROME 21; BBS21	0.03315679	2.4800449437223997
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0331189	2.4772108665117396
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.032923629999999995	2.462605159018322
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.03248864	2.430068995231966
PYCNODYSOSTOSIS	0.03246359	2.428195317899503
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.03246359	2.428195317899503
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.03246359	2.428195317899503
WITTEVEEN-KOLK SYNDROME	0.03246359	2.428195317899503
RETINITIS PIGMENTOSA 80; RP80	0.03212319	2.402734249477527
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.0316284	2.365725195292715
SERTOLI CELL-ONLY SYNDROME	0.03125	2.3374218219352656
FASCIAL DYSTROPHY, CONGENITAL	0.03125	2.3374218219352656
NIPPLES, SUPERNUMERARY	0.03125	2.3374218219352656
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.03125	2.3374218219352656
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.03125	2.3374218219352656
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.03125	2.3374218219352656
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.03125	2.3374218219352656
FIBROSCLEROSIS, MULTIFOCAL	0.03125	2.3374218219352656
BREAST, UNILATERAL GIANT	0.03125	2.3374218219352656
PYLE DISEASE; PYL	0.03125	2.3374218219352656
OCULOCEREBROCUTANEOUS SYNDROME	0.03125	2.3374218219352656
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.03125	2.3374218219352656
ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	0.03125	2.3374218219352656
GALACTORRHEA	0.03125	2.3374218219352656
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.03125	2.3374218219352656
SCALP-EAR-NIPPLE SYNDROME; SENS	0.03125	2.3374218219352656
#253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1;;LCCS;;MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE	0.03125	2.3374218219352656
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.03125	2.3374218219352656
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03125	2.3374218219352656
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.03125	2.3374218219352656
HERNIA, HIATUS	0.03125	2.3374218219352656
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.03125	2.3374218219352656
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.03125	2.3374218219352656
#615348 NEMALINE MYOPATHY 8; NEM8	0.03125	2.3374218219352656
OPTIC ATROPHY 11; OPA11	0.0311395	2.3291566983729024
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.031055	2.322836309766389
CASPASE 8 DEFICIENCY	0.03061888	2.2902156248069523
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0302376	2.261696834654393
RETINITIS PIGMENTOSA 14	0.03015235	2.2553203479241537
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.03015235	2.2553203479241537
RETINITIS PIGMENTOSA 72; RP72	0.03015235	2.2553203479241537
RETINITIS PIGMENTOSA 10; RP10	0.03015235	2.2553203479241537
RETINITIS PIGMENTOSA 19	0.03015235	2.2553203479241537
RETINITIS PIGMENTOSA 83; RP83	0.03015235	2.2553203479241537
CHERUBISM	0.03015235	2.2553203479241537
RETINITIS PIGMENTOSA 79	0.03015235	2.2553203479241537
JACOBSEN SYNDROME	0.02992591	2.2383832024086647
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.02992591	2.2383832024086647
CHROMOSOME 18Q DELETION SYNDROME	0.0298237	2.230738150107225
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.02940529	2.199442128842715
#170100 PROLIDASE DEFICIENCY	0.02940529	2.199442128842715
TRANSALDOLASE DEFICIENCY	0.02940529	2.199442128842715
MUCOPOLYSACCHARIDOSIS, TYPE II	0.02940529	2.199442128842715
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.02940529	2.199442128842715
CONE-ROD DYSTROPHY 16	0.029118750000000002	2.178009653679281
CONE DYSTROPHY 3	0.029118750000000002	2.178009653679281
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.02839504	2.1238779561831915
NEURAMINIDASE DEFICIENCY	0.02784108	2.082443134023855
DIGEORGE SYNDROME; DGS	0.02752939	2.059129501778127
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.02752939	2.059129501778127
SPONDYLOOCULAR SYNDROME; SOS	0.02752939	2.059129501778127
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02752939	2.059129501778127
WILLIAMS-BEUREN SYNDROME; WBS	0.02752939	2.059129501778127
Adrenoleukodystrophy	0.02744489	2.052809113171614
SEA-BLUE HISTIOCYTE DISEASE	0.027132589999999998	2.0294498544519217
GAUCHER DISEASE, TYPE I	0.027132589999999998	2.0294498544519217
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0270459	2.0229656593241283
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.02686591	2.0095028576047635
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.026581039999999997	1.988195294263493
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0263158	1.9683560058138898
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0263158	1.9683560058138898
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0263158	1.9683560058138898
RAHMAN SYNDROME	0.0263158	1.9683560058138898
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0263158	1.9683560058138898
#180550 RING DERMOID OF CORNEA; RDC	0.0263158	1.9683560058138898
CATARACT 17, MULTIPLE TYPES	0.0263158	1.9683560058138898
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.0263158	1.9683560058138898
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.0263158	1.9683560058138898
Muenke syndrome	0.0263158	1.9683560058138898
CATARACT, ANTERIOR POLAR, 2	0.0263158	1.9683560058138898
#604356 DUANE RETRACTION SYNDROME 2; DURS2	0.0263158	1.9683560058138898
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0263158	1.9683560058138898
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.0263158	1.9683560058138898
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0263158	1.9683560058138898
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.0263158	1.9683560058138898
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0263158	1.9683560058138898
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.0263158	1.9683560058138898
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.0263158	1.9683560058138898
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.0263158	1.9683560058138898
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.0263158	1.9683560058138898
#300814 NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6	0.0263158	1.9683560058138898
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0263158	1.9683560058138898
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.0263158	1.9683560058138898
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.0263158	1.9683560058138898
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.026213590000000002	1.9607109535124498
SECKEL SYNDROME 9; SCKL9	0.026213590000000002	1.9607109535124498
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.026213590000000002	1.9607109535124498
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.026213590000000002	1.9607109535124498
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.026213590000000002	1.9607109535124498
IMMUNODEFICIENCY 58; IMD58	0.026213590000000002	1.9607109535124498
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.026213590000000002	1.9607109535124498
ROIFMAN SYNDROME; RFMN	0.026027079999999998	1.946760472104157
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.02583231	1.9321921633598904
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.02583231	1.9321921633598904
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.02583231	1.9321921633598904
BEHR SYNDROME	0.02583231	1.9321921633598904
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.02583231	1.9321921633598904
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.02583231	1.9321921633598904
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.02583231	1.9321921633598904
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0255593	1.9117716983484812
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.025	1.8699374575482124
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.025	1.8699374575482124
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.025	1.8699374575482124
ASTHMA, SUSCEPTIBILITY TO	0.025	1.8699374575482124
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.025	1.8699374575482124
ICHTHYOSIS VULGARIS	0.025	1.8699374575482124
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.025	1.8699374575482124
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.025	1.8699374575482124
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.025	1.8699374575482124
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.025	1.8699374575482124
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.025	1.8699374575482124
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.025	1.8699374575482124
CYSTIC FIBROSIS	0.025	1.8699374575482124
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.025	1.8699374575482124
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.025	1.8699374575482124
NEUTROPHIL CHEMOTACTIC RESPONSE	0.025	1.8699374575482124
IMMUNODEFICIENCY 23; IMD23	0.025	1.8699374575482124
NETHERTON SYNDROME; NETH	0.025	1.8699374575482124
DERMATITIS, ATOPIC	0.025	1.8699374575482124
IGE RESPONSIVENESS, ATOPIC	0.025	1.8699374575482124
BARDET-BIEDL SYNDROME 1; BBS1	0.025	1.8699374575482124
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.025	1.8699374575482124
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.025	1.8699374575482124
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.02493033	1.864726315841517
KAGAMI-OGATA SYNDROME	0.024813489999999997	1.8559869761399193
GAUCHER DISEASE, PERINATAL LETHAL	0.024813489999999997	1.8559869761399193
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.02459116	1.839357248342452
THROMBOCYTHEMIA, ESSENTIAL	0.02401309	1.796119058499056
OSTEOGENESIS IMPERFECTA, TYPE V	0.02394089	1.790718679121657
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02394089	1.790718679121657
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.02371674	1.7739528198772798
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.02371674	1.7739528198772798
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.02371674	1.7739528198772798
RETINITIS PIGMENTOSA 13; RP13	0.0232558	1.7394756610099888
#608380 RETINITIS PIGMENTOSA 26; RP26	0.0232558	1.7394756610099888
RETINITIS PIGMENTOSA 69	0.0232558	1.7394756610099888
RETINITIS PIGMENTOSA 74; RP74	0.0232558	1.7394756610099888
RETINITIS PIGMENTOSA	0.0232558	1.7394756610099888
#312600 RETINITIS PIGMENTOSA 2; RP2	0.0232558	1.7394756610099888
RETINITIS PIGMENTOSA 25; RP25	0.0232558	1.7394756610099888
RETINITIS PIGMENTOSA 73; RP73	0.0232558	1.7394756610099888
RETINITIS PIGMENTOSA 1	0.0232558	1.7394756610099888
#613769 RETINITIS PIGMENTOSA 44; RP44	0.0232558	1.7394756610099888
RETINITIS PIGMENTOSA 6	0.0232558	1.7394756610099888
#608133 RETINITIS PIGMENTOSA 7; RP7RETINITIS PIGMENTOSA 7, DIGENIC, INCLUDED;;RETINITIS PIGMENTOSA 7 WITH BULL'S-EYE MACULOPATHY, INCLUDED	0.0232558	1.7394756610099888
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.0232558	1.7394756610099888
#606068 RETINITIS PIGMENTOSA 28; RP28	0.0232558	1.7394756610099888
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0232558	1.7394756610099888
#180104 RETINITIS PIGMENTOSA 9; RP9	0.0232558	1.7394756610099888
#612572 RETINITIS PIGMENTOSA 46; RP46;;RETINITIS PIGMENTOSA, AUTOSOMAL RECESSIVE, IDH3B-RELATED	0.0232558	1.7394756610099888
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.0232558	1.7394756610099888
GLAUCOMA 1, OPEN ANGLE, M	0.0232558	1.7394756610099888
#184095 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE;;SED, MAROTEAUX TYPE;;PSEUDO-MORQUIO SYNDROME, TYPE 2	0.0227273	1.6999451831574193
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0227273	1.6999451831574193
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0227273	1.6999451831574193
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0227273	1.6999451831574193
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0227273	1.6999451831574193
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0227273	1.6999451831574193
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0227273	1.6999451831574193
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0227273	1.6999451831574193
STICKLER SYNDROME, TYPE III	0.0227273	1.6999451831574193
IMINOGLYCINURIA	0.0227273	1.6999451831574193
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0227273	1.6999451831574193
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0227273	1.6999451831574193
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0227273	1.6999451831574193
UNIQUE GREEN PHENOMENON	0.0227273	1.6999451831574193
MELKERSSON-ROSENTHAL SYNDROME	0.0227273	1.6999451831574193
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0227273	1.6999451831574193
OCULAR CICATRICIAL PEMPHIGOID	0.0227273	1.6999451831574193
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0227273	1.6999451831574193
AGNATHIA-OTOCEPHALY COMPLEX	0.0227273	1.6999451831574193
DERMOIDS OF CORNEA	0.0227273	1.6999451831574193
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0227273	1.6999451831574193
CARNEY COMPLEX, TYPE 1; CNC1	0.0227273	1.6999451831574193
BLEPHAROCHALASIS AND DOUBLE LIP	0.0227273	1.6999451831574193
PUPIL, EGG-SHAPED	0.0227273	1.6999451831574193
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0227273	1.6999451831574193
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0227273	1.6999451831574193
MELANOMA, CUTANEOUS MALIGNANT	0.0227273	1.6999451831574193
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0227273	1.6999451831574193
HYPERCALCEMIA, INFANTILE, 1	0.0227273	1.6999451831574193
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0227273	1.6999451831574193
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0227273	1.6999451831574193
611426 TENTED EYEBROWS	0.0227273	1.6999451831574193
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0227273	1.6999451831574193
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.0227273	1.6999451831574193
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0227273	1.6999451831574193
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0227273	1.6999451831574193
MYELINATED OPTIC NERVE FIBERS	0.0227273	1.6999451831574193
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0227273	1.6999451831574193
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.0223676	1.673040523018216
RETINAL CONE DYSTROPHY 1; RCD1	0.0222222	1.6621649667651155
CORNEAL DYSTROPHY, LATTICE TYPE I	0.0222222	1.6621649667651155
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.0222222	1.6621649667651155
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.0222222	1.6621649667651155
Boucher-Neuhauser syndrome	0.0222222	1.6621649667651155
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.0222222	1.6621649667651155
JOUBERT SYNDROME 35; JBTS35	0.0222222	1.6621649667651155
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.0222222	1.6621649667651155
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.0222222	1.6621649667651155
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.0222222	1.6621649667651155
ANIRIDIA 3	0.0222222	1.6621649667651155
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.0222222	1.6621649667651155
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.0222222	1.6621649667651155
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.0222222	1.6621649667651155
#613862 RETINITIS PIGMENTOSA 38; RP38;;ROD-CONE DYSTROPHY, CHILDHOOD-ONSET	0.0222222	1.6621649667651155
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	0.0222222	1.6621649667651155
#613660 CONE-ROD DYSTROPHY 15; CORD15RETINITIS PIGMENTOSA 65, INCLUDED; RP65, INCLUDED	0.0222222	1.6621649667651155
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.0222222	1.6621649667651155
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.0222222	1.6621649667651155
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.0222222	1.6621649667651155
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.0222222	1.6621649667651155
BASAL LAMINAR DRUSEN	0.0222222	1.6621649667651155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0220999	1.6530172327227892
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.02194919	1.6417445017537058
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.02162179	1.6172558008096545
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.02162179	1.6172558008096545
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.02162179	1.6172558008096545
COSTELLO SYNDROME; CSTLO	0.02162179	1.6172558008096545
TEMPLE SYNDROME	0.02162179	1.6172558008096545
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.02162179	1.6172558008096545
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.02162179	1.6172558008096545
CORNEODERMATOOSSEOUS SYNDROME	0.02162179	1.6172558008096545
Diamond-Blackfan anemia 1	0.02162179	1.6172558008096545
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.02162179	1.6172558008096545
TYSHCHENKO SYNDROME	0.02162179	1.6172558008096545
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.02162179	1.6172558008096545
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.02115401	1.5822670270539785
LEBER OPTIC ATROPHY AND DYSTONIA	0.02115401	1.5822670270539785
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.02115401	1.5822670270539785
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.02115401	1.5822670270539785
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.02115401	1.5822670270539785
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.02115401	1.5822670270539785
OPTICOCOCHLEODENTATE DEGENERATION	0.02115401	1.5822670270539785
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.02115401	1.5822670270539785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.02115401	1.5822670270539785
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.526482304845417
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	1.526482304845417
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.526482304845417
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.526482304845417
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.020408199999999998	1.526482304845417
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.526482304845417
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.526482304845417
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.020408199999999998	1.526482304845417
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.020408199999999998	1.526482304845417
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	1.526482304845417
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.526482304845417
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	1.526482304845417
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.020408199999999998	1.526482304845417
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.526482304845417
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.020408199999999998	1.526482304845417
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.020408199999999998	1.526482304845417
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.526482304845417
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	1.526482304845417
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020408199999999998	1.526482304845417
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.020408199999999998	1.526482304845417
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	1.526482304845417
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.526482304845417
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	1.526482304845417
NEMALINE MYOPATHY 10	0.020408199999999998	1.526482304845417
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	1.526482304845417
YUNIS-VARON SYNDROME	0.020408199999999998	1.526482304845417
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	1.526482304845417
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.526482304845417
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	1.4666143872045536
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0196078	1.4666143872045536
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	1.4666143872045536
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	1.4666143872045536
RAYNAUD DISEASE	0.0196078	1.4666143872045536
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	1.4666143872045536
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	1.4666143872045536
MONOPHALANGY OF GREAT TOE	0.0196078	1.4666143872045536
MEGAEPIPHYSEAL DWARFISM	0.0196078	1.4666143872045536
SPINAL ARACHNOIDITIS	0.0196078	1.4666143872045536
HHHH SYNDROME	0.0196078	1.4666143872045536
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	1.4666143872045536
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	1.4666143872045536
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	1.4666143872045536
VESICOURETERAL REFLUX 1	0.0196078	1.4666143872045536
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0196078	1.4666143872045536
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	1.4666143872045536
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	1.4666143872045536
NEPHROSIALIDOSIS	0.0196078	1.4666143872045536
VAN DEN BOSCH SYNDROME	0.0196078	1.4666143872045536
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	1.4666143872045536
KNUCKLE PADS	0.0196078	1.4666143872045536
CARPAL DISPLACEMENT	0.0196078	1.4666143872045536
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	1.4666143872045536
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	1.4666143872045536
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	1.4666143872045536
LETTERER-SIWE DISEASE	0.0196078	1.4666143872045536
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	1.4666143872045536
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	1.4666143872045536
THROMBOCYTOPENIA 3	0.0196078	1.4666143872045536
PUBIC BONE DYSPLASIA	0.0196078	1.4666143872045536
#215300 CHONDROSARCOMA	0.0196078	1.4666143872045536
BAND HETEROTOPIA; BH	0.0196078	1.4666143872045536
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	1.4666143872045536
DOUBLE NAIL FOR FIFTH TOE	0.0196078	1.4666143872045536
TOE, MISSHAPEN	0.0196078	1.4666143872045536
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	1.4666143872045536
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	1.4666143872045536
THUMBS, CONGENITAL CLASPED	0.0196078	1.4666143872045536
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	1.4666143872045536
THALIDOMIDE SUSCEPTIBILITY	0.0196078	1.4666143872045536
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	1.4666143872045536
PACHYDERMODACTYLY, FAMILIAL	0.0196078	1.4666143872045536
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	1.4666143872045536
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	1.4666143872045536
TRACHEOBRONCHOMEGALY	0.0196078	1.4666143872045536
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	1.4666143872045536
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	1.4666143872045536
WHITE-SUTTON SYNDROME; WHSUS	0.0189082	1.4142860573925244
ZTTK SYNDROME; ZTTKS	0.0189082	1.4142860573925244
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0189082	1.4142860573925244
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.01875749	1.4030133264234408
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.01875749	1.4030133264234408
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.01875749	1.4030133264234408
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01848979	1.3829900361280143
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.01791639	1.3401011506016887
COHEN SYNDROME	0.01789309	1.3383583688912537
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.01769461	1.323512561428287
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.01769461	1.323512561428287
SCHINDLER DISEASE, TYPE I	0.01769461	1.323512561428287
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.01769461	1.323512561428287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.01769461	1.323512561428287
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.01769461	1.323512561428287
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.01769461	1.323512561428287
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.01769461	1.323512561428287
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.01769461	1.323512561428287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.01769461	1.323512561428287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.01769461	1.323512561428287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0175439	1.3122398304592033
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.0175439	1.3122398304592033
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0175439	1.3122398304592033
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0175439	1.3122398304592033
BRITTLE CORNEA SYNDROME	0.0175439	1.3122398304592033
RETINAL ARTERIES, TORTUOSITY OF	0.0175439	1.3122398304592033
PEROXISOME BIOGENESIS DISORDER 11B	0.0175439	1.3122398304592033
CATARACT 44; CTRCT44	0.0175439	1.3122398304592033
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0175439	1.3122398304592033
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.0175439	1.3122398304592033
NANCE-HORAN SYNDROME	0.0175439	1.3122398304592033
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.0175439	1.3122398304592033
KNOBLOCH SYNDROME 1; KNO1	0.0175439	1.3122398304592033
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0175439	1.3122398304592033
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0175439	1.3122398304592033
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0175439	1.3122398304592033
MYOCLONIC EPILEPSY OF LAFORA	0.0175439	1.3122398304592033
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.0175439	1.3122398304592033
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.0175439	1.3122398304592033
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.0175439	1.3122398304592033
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.0175439	1.3122398304592033
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0175439	1.3122398304592033
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0175439	1.3122398304592033
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.01747468	1.3070623476267438
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01747468	1.3070623476267438
CHROMOSOME Xp11.3 DELETION SYNDROME	0.01728742	1.2930557680947248
#133780 EXUDATIVE VITREORETINOPATHY 1; EVR1;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, AUTOSOMAL DOMINANT;;FEVR, AUTOSOMAL DOMINANT;;CRISWICK-SCHEPENS SYNDROMERETINOPATHY OF PREMATURITY, INCLUDED; ROP, INCLUDED	0.01679754	1.256413969626576
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.01679754	1.256413969626576
EXUDATIVE VITREORETINOPATHY 4	0.01679754	1.256413969626576
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.0166795	1.2475848729270163
RETINITIS PIGMENTOSA 27; RP27	0.01607383	1.2022822721304873
CYSTINOSIS, NEPHROPATHIC; CTNS	0.01551987	1.160847449971151
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.015401829999999998	1.1520183532715913
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.01529809	1.1442588607977493
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.01529809	1.1442588607977493
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.01529809	1.1442588607977493
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.01472469	1.1013699752714234
LOWE OCULOCEREBRORENAL SYNDROME	0.01428298	1.0683311722964788
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.01428298	1.0683311722964788
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.014188240000000001	1.061244857307354
PHELAN-MCDERMID SYNDROME; PHMDS	0.0140845	1.0534853648335119
SUDANOPHILIC CEREBRAL SCLEROSIS	0.0140845	1.0534853648335119
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0140845	1.0534853648335119
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0140845	1.0534853648335119
YOU-HOOVER-FONG SYNDROME; YHFS	0.0140845	1.0534853648335119
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0140845	1.0534853648335119
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0140845	1.0534853648335119
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.0140845	1.0534853648335119
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.0140845	1.0534853648335119
Glycosylphosphatidylinositol biosynthesis defect 18	0.0140845	1.0534853648335119
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.0140845	1.0534853648335119
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.0140845	1.0534853648335119
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0140845	1.0534853648335119
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0140845	1.0534853648335119
RAYNAUD-CLAES SYNDROME; MRXSRC	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0140845	1.0534853648335119
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0140845	1.0534853648335119
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0140845	1.0534853648335119
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0140845	1.0534853648335119
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.0140845	1.0534853648335119
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0140845	1.0534853648335119
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.0140845	1.0534853648335119
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.0140845	1.0534853648335119
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.0140845	1.0534853648335119
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0140845	1.0534853648335119
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0140845	1.0534853648335119
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.0140845	1.0534853648335119
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.0140845	1.0534853648335119
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.0140845	1.0534853648335119
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.0140845	1.0534853648335119
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0140845	1.0534853648335119
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0140845	1.0534853648335119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0140845	1.0534853648335119
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0140845	1.0534853648335119
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0140845	1.0534853648335119
KRABBE DISEASE	0.0135111	1.010596479307186
CANAVAN DISEASE	0.0135111	1.010596479307186
DYSOSTEOSCLEROSIS	0.0135111	1.010596479307186
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.0135111	1.010596479307186
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.0135111	1.010596479307186
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0135111	1.010596479307186
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0135111	1.010596479307186
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.01306939	0.9775576763322413
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.01306939	0.9775576763322413
CONE DYSTROPHY 4	0.01306939	0.9775576763322413
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.01306939	0.9775576763322413
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.01306939	0.9775576763322413
#615431 MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23	0.01306939	0.9775576763322413
#300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A;;CSNB, INCOMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2	0.01306939	0.9775576763322413
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.01306939	0.9775576763322413
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.01306939	0.9775576763322413
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.01306939	0.9775576763322413
#608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A;;LATTICE CORNEAL DYSTROPHY, TYPE IIIA	0.01306939	0.9775576763322413
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.01306939	0.9775576763322413
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.01306939	0.9775576763322413
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.01306939	0.9775576763322413
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.01306939	0.9775576763322413
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.01306939	0.9775576763322413
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.01306939	0.9775576763322413
BLUE CONE MONOCHROMACY; BCM	0.01306939	0.9775576763322413
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.01306939	0.9775576763322413
FOCAL DERMAL HYPOPLASIA; FDH	0.011720250000000002	0.8766453794731776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.011720250000000002	0.8766453794731776
RODRIGUES BLINDNESS	0.01111458	0.8313427786766485
WEILL-MARCHESANI SYNDROME 1; WMS1	0.01111458	0.8313427786766485
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.01111458	0.8313427786766485
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.01111458	0.8313427786766485
RENPENNING SYNDROME 1; RENS1	0.01111458	0.8313427786766485
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.010996539999999999	0.8225136819770887
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.010996539999999999	0.8225136819770887
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.010996539999999999	0.8225136819770887
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.010996539999999999	0.8225136819770887
TANGIER DISEASE; TGD	0.01057813	0.7912176607125789
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.010506660000000001	0.7858718835089401
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.010506660000000001	0.7858718835089401
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.010506660000000001	0.7858718835089401
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.010506660000000001	0.7858718835089401
USHER SYNDROME, TYPE IID; USH2D	0.00990099	0.740569282712411
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00990099	0.740569282712411
STICKLER SYNDROME, TYPE I	0.00990099	0.740569282712411
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00990099	0.740569282712411
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.00990099	0.740569282712411
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.00990099	0.740569282712411
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00990099	0.740569282712411
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00990099	0.740569282712411
XYLOSIDASE DEFICIENCY	0.00990099	0.740569282712411
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00990099	0.740569282712411
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.00990099	0.740569282712411
RETINITIS PIGMENTOSA 71; RP71	0.00990099	0.740569282712411
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.00990099	0.740569282712411
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.00990099	0.740569282712411
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.740569282712411
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.00990099	0.740569282712411
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.00990099	0.740569282712411
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00990099	0.740569282712411
PIERSON SYNDROME	0.00990099	0.740569282712411
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00990099	0.740569282712411
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00990099	0.740569282712411
VITREORETINOCHOROIDOPATHY; VRCP	0.00990099	0.740569282712411
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00990099	0.740569282712411
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.00990099	0.740569282712411
SORSBY FUNDUS DYSTROPHY; SFD	0.00990099	0.740569282712411
FREESIA FLOWERS, INABILITY TO SMELL	0.00990099	0.740569282712411
FLECK RETINA OF KANDORI	0.00990099	0.740569282712411
TAY-SACHS DISEASE; TSD	0.00990099	0.740569282712411
EHLERS-DANLOS SYNDROME, TYPE VI	0.00990099	0.740569282712411
JOUBERT SYNDROME 6	0.00990099	0.740569282712411
RETINITIS PIGMENTOSA 29; RP29	0.00990099	0.740569282712411
ARIMA SYNDROME	0.00990099	0.740569282712411
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00990099	0.740569282712411
RETINITIS PIGMENTOSA 35; RP35	0.00990099	0.740569282712411
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.00990099	0.740569282712411
GM2-GANGLIOSIDOSIS, AB VARIANT	0.00990099	0.740569282712411
#601553 HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD;;HYPOTRICHOSIS WITH CONE-ROD DYSTROPHY	0.00990099	0.740569282712411
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.00990099	0.740569282712411
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00990099	0.740569282712411
TEMPORAL ARTERITIS	0.00990099	0.740569282712411
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.00990099	0.740569282712411
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00990099	0.740569282712411
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00990099	0.740569282712411
SANDHOFF DISEASE	0.00990099	0.740569282712411
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00990099	0.740569282712411
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.00990099	0.740569282712411
MICROPHTHALMIA, SYNDROMIC 1	0.00990099	0.740569282712411
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.00990099	0.740569282712411
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.00990099	0.740569282712411
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.00990099	0.740569282712411
MUSK, INABILITY TO SMELL	0.00990099	0.740569282712411
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00990099	0.740569282712411
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.00990099	0.740569282712411
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00990099	0.740569282712411
#216900 ACHROMATOPSIA 2; ACHM2;;COLORBLINDNESS, TOTAL;;ROD MONOCHROMATISM 2;;ROD MONOCHROMACY 2; RMCH2	0.00990099	0.740569282712411
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00990099	0.740569282712411
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.00990099	0.740569282712411
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00990099	0.740569282712411
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00990099	0.740569282712411
WEBB-DATTANI SYNDROME; WEDAS	0.00990099	0.740569282712411
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.00990099	0.740569282712411
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.00990099	0.740569282712411
#607921 RETINITIS PIGMENTOSA 30; RP30	0.00978295	0.7317401860128514
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00978295	0.7317401860128514
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00978295	0.7317401860128514
JABERI-ELAHI SYNDROME; JABELS	0.00978295	0.7317401860128514
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00978295	0.7317401860128514
FUMARASE DEFICIENCY; FMRD	0.00978295	0.7317401860128514
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.00978295	0.7317401860128514
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00978295	0.7317401860128514
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00978295	0.7317401860128514
CROUZON SYNDROME	0.00978295	0.7317401860128514
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00978295	0.7317401860128514
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00978295	0.7317401860128514
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00978295	0.7317401860128514
XFE PROGEROID SYNDROME; XFEPS	0.00978295	0.7317401860128514
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00978295	0.7317401860128514
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00978295	0.7317401860128514
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00978295	0.7317401860128514
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00978295	0.7317401860128514
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.00978295	0.7317401860128514
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00978295	0.7317401860128514
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00978295	0.7317401860128514
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00978295	0.7317401860128514
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00978295	0.7317401860128514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00978295	0.7317401860128514
CHROMOSOME 1P36 DELETION SYNDROME	0.00978295	0.7317401860128514
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00978295	0.7317401860128514
FILIPPI SYNDROME; FLPIS	0.00978295	0.7317401860128514
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00978295	0.7317401860128514
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00978295	0.7317401860128514
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00978295	0.7317401860128514
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.009228990000000001	0.6903053638535152
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00811014	0.6066181828784023
COCKAYNE SYNDROME A; CSA	0.0080154	0.5995318678892777
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.0080154	0.5995318678892777
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.0080154	0.5995318678892777
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0080154	0.5995318678892777
COMBINED SAPOSIN DEFICIENCY	0.0080154	0.5995318678892777
Polyarteritis nodosa, childhood-onset	0.0080154	0.5995318678892777
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.007386429999999999	0.5524864853823136
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.007386429999999999	0.5524864853823136
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.007386429999999999	0.5524864853823136
COFFIN-SIRIS SYNDROME 2; CSS2	0.007386429999999999	0.5524864853823136
Helsmoortel-van der Aa syndrome	0.007386429999999999	0.5524864853823136
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.007386429999999999	0.5524864853823136
COFFIN-SIRIS SYNDROME 4; CSS4	0.007386429999999999	0.5524864853823136
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.007386429999999999	0.5524864853823136
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.007386429999999999	0.5524864853823136
COFFIN-SIRIS SYNDROME 3; CSS3	0.007386429999999999	0.5524864853823136
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.007386429999999999	0.5524864853823136
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.007386429999999999	0.5524864853823136
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007386429999999999	0.5524864853823136
COFFIN-SIRIS SYNDROME 1; CSS1	0.007386429999999999	0.5524864853823136
#204870 CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD;;CDGDL;;AMYLOIDOSIS, CORNEAL;;AMYLOID CORNEAL DYSTROPHY, JAPANESE TYPE;;CORNEAL DYSTROPHY, LATTICE TYPE III;;LATTICE CORNEAL DYSTROPHY, TYPE III	0.00689655	0.515844686914165
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00689655	0.515844686914165
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.00689655	0.515844686914165
MEGALOCORNEA	0.00689655	0.515844686914165
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.00689655	0.515844686914165
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00689655	0.515844686914165
RETINITIS PIGMENTOSA 51; RP51	0.00689655	0.515844686914165
RETINITIS PIGMENTOSA 60; RP60	0.00689655	0.515844686914165
NANOPHTHALMOS 4; NNO4	0.00689655	0.515844686914165
#603786 STARGARDT DISEASE 4; STGD4	0.00689655	0.515844686914165
LEBER CONGENITAL AMAUROSIS 16	0.00689655	0.515844686914165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00689655	0.515844686914165
RETINITIS PIGMENTOSA 77; RP77	0.00689655	0.515844686914165
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00689655	0.515844686914165
#616118 MACULAR DEGENERATION, EARLY-ONSET; EOMD	0.00689655	0.515844686914165
RETINITIS PIGMENTOSA 56; RP56	0.00689655	0.515844686914165
MICROPHTHALMIA, ISOLATED 5	0.00689655	0.515844686914165
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00689655	0.515844686914165
SENIOR-LOKEN SYNDROME 8; SLSN8	0.00689655	0.515844686914165
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00689655	0.515844686914165
#611809 BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB	0.00689655	0.515844686914165
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00689655	0.515844686914165
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.00689655	0.515844686914165
PSEUDOXANTHOMA ELASTICUM; PXE	0.00689655	0.515844686914165
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00689655	0.515844686914165
#300834 MACULAR DEGENERATION, X-LINKED ATROPHIC	0.00689655	0.515844686914165
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00689655	0.515844686914165
JOUBERT SYNDROME 30; JBTS30	0.00689655	0.515844686914165
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00689655	0.515844686914165
FOVEAL HYPOPLASIA 2; FVH2	0.00689655	0.515844686914165
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00689655	0.515844686914165
CONE-ROD DYSTROPHY 5; CORD5	0.00689655	0.515844686914165
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00689655	0.515844686914165
#615420 MYOPIA 22, AUTOSOMAL DOMINANT; MYP22	0.00689655	0.515844686914165
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00689655	0.515844686914165
#613194 RETINITIS PIGMENTOSA 50; RP50RETINITIS PIGMENTOSA, CONCENTRIC, INCLUDED	0.00689655	0.515844686914165
EDICT SYNDROME	0.00689655	0.515844686914165
#305390 EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2;;EVRX;;FEVR, X-LINKED; FEVRX	0.00689655	0.515844686914165
#612657 CONE-ROD DYSTROPHY 12; CORD12	0.00689655	0.515844686914165
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00689655	0.515844686914165
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00689655	0.515844686914165
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00689655	0.515844686914165
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.00689655	0.515844686914165
CORNEAL DYSTROPHY, MEESMANN	0.00689655	0.515844686914165
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.00689655	0.515844686914165
#613270 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00689655	0.515844686914165
#614076 HERMANSKY-PUDLAK SYNDROME 7; HPS7	0.00689655	0.515844686914165
RETINITIS PIGMENTOSA 76; RP76	0.00689655	0.515844686914165
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00689655	0.515844686914165
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00689655	0.515844686914165
STARGARDT DISEASE 3; STGD3	0.00689655	0.515844686914165
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.00689655	0.515844686914165
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.00689655	0.515844686914165
#607541 CORNEAL DYSTROPHY, AVELLINO TYPE; CDA;;ACD;;AVELLINO CORNEAL DYSTROPHY;;COMBINED GRANULAR-LATTICE CORNEAL DYSTROPHY;;GRANULAR CORNEAL DYSTROPHY, TYPE II; CGD2	0.00689655	0.515844686914165
RETINITIS PIGMENTOSA 85; RP85	0.00689655	0.515844686914165
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00689655	0.515844686914165
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.00689655	0.515844686914165
#610024 RETINAL CONE DYSTROPHY 3A; RCD3A;;CONE DYSTROPHY WITH NIGHT BLINDNESS AND SUPERNORMAL ROD RESPONSES,PDE6H-RELATEDACHROMATOPSIA 6, INCLUDED; ACHM6, INCLUDED	0.00689655	0.515844686914165
CONE-ROD DYSTROPHY 21; CORD21	0.00689655	0.515844686914165
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00689655	0.515844686914165
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00689655	0.515844686914165
KERATOCONUS 9; KTCN9	0.00689655	0.515844686914165
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00689655	0.515844686914165
#608194 CONE-ROD DYSTROPHY 13; CORD13	0.00689655	0.515844686914165
COLOBOMA, OCULAR	0.00689655	0.515844686914165
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00689655	0.515844686914165
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00689655	0.515844686914165
#613856 ACHROMATOPSIA 4; ACHM4	0.00617284	0.46171298941807626
#610359 RETINITIS PIGMENTOSA 33; RP33	0.00617284	0.46171298941807626
#606574 ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV	0.00617284	0.46171298941807626
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00617284	0.46171298941807626
#612775 CONE-ROD DYSTROPHY 9; CORD9	0.00617284	0.46171298941807626
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00617284	0.46171298941807626
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00617284	0.46171298941807626
#606952 ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B;;OCULOCUTANEOUS ALBINISM, TYPE IB;;ALBINISM, YELLOW MUTANT TYPE;;YELLOW ALBINISMALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;;OCA1-TS, INCLUDED	0.00617284	0.46171298941807626
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00617284	0.46171298941807626
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00617284	0.46171298941807626
GILLESPIE SYNDROME; GLSP	0.00617284	0.46171298941807626
#613268 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00617284	0.46171298941807626
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00617284	0.46171298941807626
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00617284	0.46171298941807626
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00617284	0.46171298941807626
N SYNDROME	0.00617284	0.46171298941807626
BIRDSHOT CHORIORETINOPATHY	0.00617284	0.46171298941807626
HEART AND BRAIN MALFORMATION SYNDROME	0.00617284	0.46171298941807626
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.00617284	0.46171298941807626
#613758 RETINITIS PIGMENTOSA 47; RP47	0.00617284	0.46171298941807626
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00617284	0.46171298941807626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00617284	0.46171298941807626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00617284	0.46171298941807626
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00617284	0.46171298941807626
BAKER-GORDON SYNDROME; BAGOS	0.00617284	0.46171298941807626
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00617284	0.46171298941807626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00617284	0.46171298941807626
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00617284	0.46171298941807626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00617284	0.46171298941807626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00617284	0.46171298941807626
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.00617284	0.46171298941807626
CREUTZFELDT-JAKOB DISEASE; CJD	0.00617284	0.46171298941807626
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00617284	0.46171298941807626
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00617284	0.46171298941807626
PEROXISOME BIOGENESIS DISORDER 6B	0.00617284	0.46171298941807626
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00617284	0.46171298941807626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00617284	0.46171298941807626
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00617284	0.46171298941807626
PEROXISOME BIOGENESIS DISORDER 5B	0.00617284	0.46171298941807626
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00617284	0.46171298941807626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00617284	0.46171298941807626
#613829 LEBER CONGENITAL AMAUROSIS 7; LCA7	0.00617284	0.46171298941807626
#603649 CONE-ROD DYSTROPHY 7; CORD7	0.00617284	0.46171298941807626
ALBINISM, OCULAR, TYPE I	0.00617284	0.46171298941807626
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.00617284	0.46171298941807626
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00617284	0.46171298941807626
#613827 RETINITIS PIGMENTOSA 48; RP48	0.00617284	0.46171298941807626
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00617284	0.46171298941807626
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00617284	0.46171298941807626
JOUBERT SYNDROME 2	0.00617284	0.46171298941807626
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00617284	0.46171298941807626
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00617284	0.46171298941807626
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00617284	0.46171298941807626
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00617284	0.46171298941807626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00617284	0.46171298941807626
#614180 RETINITIS PIGMENTOSA 61; RP61	0.00617284	0.46171298941807626
HYPERTRYPTOPHANEMIA; HYPTRP	0.00617284	0.46171298941807626
JOUBERT SYNDROME 3; JBTS3	0.00617284	0.46171298941807626
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.00617284	0.46171298941807626
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00617284	0.46171298941807626
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00617284	0.46171298941807626
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.00617284	0.46171298941807626
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00617284	0.46171298941807626
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00617284	0.46171298941807626
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.00617284	0.46171298941807626
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.00617284	0.46171298941807626
#613428 RETINITIS PIGMENTOSA 54; RP54	0.00617284	0.46171298941807626
SPASTIC PARAPLEGIA 16, X-LINKED	0.00617284	0.46171298941807626
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00561888	0.42027816725874
HURLER SYNDROME	0.00561888	0.42027816725874
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00561888	0.42027816725874
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00561888	0.42027816725874
HURLER-SCHEIE SYNDROME	0.00561888	0.42027816725874
IMMUNODEFICIENCY 36; IMD36	0.00561888	0.42027816725874
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00561888	0.42027816725874
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00561888	0.42027816725874
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00561888	0.42027816725874
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00561888	0.42027816725874
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00561888	0.42027816725874
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00561888	0.42027816725874
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.00561888	0.42027816725874
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00561888	0.42027816725874
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00561888	0.42027816725874
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00561888	0.42027816725874
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.00561888	0.42027816725874
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00561888	0.42027816725874
NIEMANN-PICK DISEASE, TYPE A	0.00561888	0.42027816725874
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00561888	0.42027816725874
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00561888	0.42027816725874
LYMPHEDEMA, HEREDITARY, III	0.00561888	0.42027816725874
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00561888	0.42027816725874
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00561888	0.42027816725874
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00561888	0.42027816725874
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.00561888	0.42027816725874
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00561888	0.42027816725874
NIEMANN-PICK DISEASE, TYPE B	0.00561888	0.42027816725874
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0048237	0.3608006925590125
PELIZAEUS-MERZBACHER DISEASE	0.0048237	0.3608006925590125
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0048237	0.3608006925590125
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0048237	0.3608006925590125
WARBURG MICRO SYNDROME 1	0.0048237	0.3608006925590125
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.0048237	0.3608006925590125
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0048237	0.3608006925590125
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0048237	0.3608006925590125
CRANIOLENTICULOSUTURAL DYSPLASIA	0.0048237	0.3608006925590125
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.0048237	0.3608006925590125
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.0048237	0.3608006925590125
CORNELIA DE LANGE SYNDROME 1	0.0048237	0.3608006925590125
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.0048237	0.3608006925590125
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0048237	0.3608006925590125
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0048237	0.3608006925590125
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.0048237	0.3608006925590125
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0048237	0.3608006925590125
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0048237	0.3608006925590125
CHOPS SYNDROME; CHOPS	0.0048237	0.3608006925590125
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0048237	0.3608006925590125
INCONTINENTIA PIGMENTI; IP	0.0048237	0.3608006925590125
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0048237	0.3608006925590125
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00440529	0.32950467129450256
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.00440529	0.32950467129450256
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00440529	0.32950467129450256
IMMUNODEFICIENCY 52; IMD52	0.00440529	0.32950467129450256
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00440529	0.32950467129450256
REYNOLDS SYNDROME	0.00440529	0.32950467129450256
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.00440529	0.32950467129450256
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00440529	0.32950467129450256
APOLIPOPROTEIN C-II DEFICIENCY	0.00440529	0.32950467129450256
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00440529	0.32950467129450256
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00440529	0.32950467129450256
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00440529	0.32950467129450256
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00440529	0.32950467129450256
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00440529	0.32950467129450256
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00440529	0.32950467129450256
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.00440529	0.32950467129450256
HEMOGLOBIN--BETA LOCUS	0.00440529	0.32950467129450256
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00440529	0.32950467129450256
ZIMMERMANN-LABAND SYNDROME 1	0.00440529	0.32950467129450256
HEMOCHROMATOSIS, TYPE 2B	0.00440529	0.32950467129450256
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.00440529	0.32950467129450256
GLYCOGEN STORAGE DISEASE IXC	0.00440529	0.32950467129450256
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00440529	0.32950467129450256
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00440529	0.32950467129450256
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.00440529	0.32950467129450256
GALACTOSE EPIMERASE DEFICIENCY	0.00440529	0.32950467129450256
MACROCEPHALY/AUTISM SYNDROME	0.00440529	0.32950467129450256
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.00440529	0.32950467129450256
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.00440529	0.32950467129450256
SPHEROCYTOSIS, TYPE 2	0.00440529	0.32950467129450256
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.00440529	0.32950467129450256
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.00440529	0.32950467129450256
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00440529	0.32950467129450256
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00440529	0.32950467129450256
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00440529	0.32950467129450256
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.00440529	0.32950467129450256
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00440529	0.32950467129450256
HYPERLIPOPROTEINEMIA, TYPE ID	0.00440529	0.32950467129450256
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.00440529	0.32950467129450256
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00440529	0.32950467129450256
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00440529	0.32950467129450256
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.00440529	0.32950467129450256
ADAMS-OLIVER SYNDROME 5; AOS5	0.00440529	0.32950467129450256
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.00440529	0.32950467129450256
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00440529	0.32950467129450256
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00440529	0.32950467129450256
NEPHRONOPHTHISIS 19; NPHP19	0.00440529	0.32950467129450256
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.00440529	0.32950467129450256
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00440529	0.32950467129450256
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00440529	0.32950467129450256
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00440529	0.32950467129450256
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00440529	0.32950467129450256
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.00440529	0.32950467129450256
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00440529	0.32950467129450256
Lipodystrophy, congenital generalized, type 1	0.00440529	0.32950467129450256
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00440529	0.32950467129450256
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00440529	0.32950467129450256
IMMUNODEFICIENCY 16	0.00440529	0.32950467129450256
TYROSINEMIA, TYPE I; TYRSN1	0.00440529	0.32950467129450256
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.00440529	0.32950467129450256
HARDIKAR SYNDROME	0.00440529	0.32950467129450256
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00440529	0.32950467129450256
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00440529	0.32950467129450256
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.00440529	0.32950467129450256
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00440529	0.32950467129450256
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.00440529	0.32950467129450256
HEMOCHROMATOSIS, TYPE 1	0.00440529	0.32950467129450256
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00440529	0.32950467129450256
PORTAL HYPERTENSION, NONCIRRHOTIC	0.00440529	0.32950467129450256
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.00440529	0.32950467129450256
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00440529	0.32950467129450256
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00440529	0.32950467129450256
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.00440529	0.32950467129450256
PROTEUS SYNDROME	0.00440529	0.32950467129450256
GAUCHER DISEASE, TYPE IIIC	0.00440529	0.32950467129450256
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00440529	0.32950467129450256
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00440529	0.32950467129450256
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.00440529	0.32950467129450256
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00440529	0.32950467129450256
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00440529	0.32950467129450256
IMMUNODEFICIENCY 47	0.00440529	0.32950467129450256
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00440529	0.32950467129450256
ELLIPTOCYTOSIS 1; EL1	0.00440529	0.32950467129450256
SICKLE CELL ANEMIA	0.00440529	0.32950467129450256
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00440529	0.32950467129450256
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00440529	0.32950467129450256
GLYCOGEN STORAGE DISEASE II	0.00440529	0.32950467129450256
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00440529	0.32950467129450256
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00440529	0.32950467129450256
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.00440529	0.32950467129450256
NIEMANN-PICK DISEASE, TYPE C2	0.00440529	0.32950467129450256
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.00440529	0.32950467129450256
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.00440529	0.32950467129450256
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.00440529	0.32950467129450256
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00440529	0.32950467129450256
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.00440529	0.32950467129450256
FELTY SYNDROME	0.00440529	0.32950467129450256
MECKEL SYNDROME, TYPE 1; MKS1	0.00440529	0.32950467129450256
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.00440529	0.32950467129450256
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00440529	0.32950467129450256
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00440529	0.32950467129450256
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00440529	0.32950467129450256
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00440529	0.32950467129450256
TRIMETHYLAMINURIA	0.00440529	0.32950467129450256
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00440529	0.32950467129450256
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.00440529	0.32950467129450256
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.00440529	0.32950467129450256
GLYCOPROTEIN STORAGE DISEASE	0.00440529	0.32950467129450256
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.00440529	0.32950467129450256
IMMUNODEFICIENCY 60; IMD60	0.00440529	0.32950467129450256
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.00440529	0.32950467129450256
HYPER-IGD SYNDROME	0.00440529	0.32950467129450256
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.00440529	0.32950467129450256
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00440529	0.32950467129450256
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.00440529	0.32950467129450256
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00440529	0.32950467129450256
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00440529	0.32950467129450256
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00440529	0.32950467129450256
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00440529	0.32950467129450256
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.00440529	0.32950467129450256
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00440529	0.32950467129450256
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00440529	0.32950467129450256
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00440529	0.32950467129450256
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00440529	0.32950467129450256
SCLEROSING CHOLANGITIS, NEONATAL	0.00440529	0.32950467129450256
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.00440529	0.32950467129450256
SPLENOPORTAL VASCULAR ANOMALIES	0.00440529	0.32950467129450256
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.00440529	0.32950467129450256
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00440529	0.32950467129450256
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00440529	0.32950467129450256
SITOSTEROLEMIA	0.00440529	0.32950467129450256
GAUCHER DISEASE, TYPE II	0.00440529	0.32950467129450256
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00440529	0.32950467129450256
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.00440529	0.32950467129450256
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.00440529	0.32950467129450256
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00440529	0.32950467129450256
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00440529	0.32950467129450256
HEMOCHROMATOSIS, TYPE 2A	0.00440529	0.32950467129450256
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.00440529	0.32950467129450256
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00440529	0.32950467129450256
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.00440529	0.32950467129450256
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00440529	0.32950467129450256
Lipodystrophy, congenital generalized, type 2	0.00440529	0.32950467129450256
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.00440529	0.32950467129450256
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.00440529	0.32950467129450256
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00440529	0.32950467129450256
HYPERLIPOPROTEINEMIA, TYPE I	0.00440529	0.32950467129450256
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00440529	0.32950467129450256
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00440529	0.32950467129450256
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00440529	0.32950467129450256
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.00440529	0.32950467129450256
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00440529	0.32950467129450256
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00440529	0.32950467129450256
IMMUNODEFICIENCY 32B; IMD32B	0.00440529	0.32950467129450256
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00440529	0.32950467129450256
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00440529	0.32950467129450256
SPHEROCYTOSIS, TYPE 1; SPH1	0.00440529	0.32950467129450256
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00440529	0.32950467129450256
AICARDI-GOUTIERES SYNDROME 7	0.00440529	0.32950467129450256
AICARDI SYNDROME; AIC	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00361011	0.2700271965947751
OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS	0.00361011	0.2700271965947751
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00361011	0.2700271965947751
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00361011	0.2700271965947751
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00361011	0.2700271965947751
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00361011	0.2700271965947751
OPTIC ATROPHY 2	0.00361011	0.2700271965947751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00361011	0.2700271965947751
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.00361011	0.2700271965947751
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.00361011	0.2700271965947751
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00361011	0.2700271965947751
LISSENCEPHALY 8; LIS8	0.00361011	0.2700271965947751
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00361011	0.2700271965947751
LISSENCEPHALY 5; LIS5	0.00361011	0.2700271965947751
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00361011	0.2700271965947751
MENTAL RETARDATION, X-LINKED 104; MRX104	0.00361011	0.2700271965947751
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.00361011	0.2700271965947751
ADAMS-OLIVER SYNDROME 2; AOS2	0.00361011	0.2700271965947751
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00361011	0.2700271965947751
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.00361011	0.2700271965947751
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.00361011	0.2700271965947751
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00361011	0.2700271965947751
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00361011	0.2700271965947751
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00361011	0.2700271965947751
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00361011	0.2700271965947751
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.00361011	0.2700271965947751
OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME	0.00361011	0.2700271965947751
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00361011	0.2700271965947751
TARP SYNDROME; TARPS	0.00361011	0.2700271965947751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.00361011	0.2700271965947751
GAPO SYNDROME; GAPOS	0.00361011	0.2700271965947751
Temtamy preaxial brachydactyly syndrome	0.00361011	0.2700271965947751
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00361011	0.2700271965947751
WOLFRAM SYNDROME 2; WFS2	0.00361011	0.2700271965947751
ROIFMAN-CHITAYAT SYNDROME	0.00361011	0.2700271965947751
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00361011	0.2700271965947751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00361011	0.2700271965947751
ACROCALLOSAL SYNDROME; ACLS	0.00361011	0.2700271965947751
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.00361011	0.2700271965947751
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00361011	0.2700271965947751
LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO	0.00361011	0.2700271965947751
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.00361011	0.2700271965947751
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00361011	0.2700271965947751
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00361011	0.2700271965947751
#608553 LEBER CONGENITAL AMAUROSIS 9; LCA9	0.00361011	0.2700271965947751
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.00361011	0.2700271965947751
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00361011	0.2700271965947751
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00361011	0.2700271965947751
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.00361011	0.2700271965947751
METACHROMATIC LEUKODYSTROPHY	0.00361011	0.2700271965947751
HAREL-YOON SYNDROME; HAYOS	0.00361011	0.2700271965947751
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00361011	0.2700271965947751
SPINOCEREBELLAR ATAXIA 13	0.00361011	0.2700271965947751
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00361011	0.2700271965947751
LEIGH SYNDROME; LS	0.00361011	0.2700271965947751
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00361011	0.2700271965947751
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00361011	0.2700271965947751
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00361011	0.2700271965947751
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00361011	0.2700271965947751
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00361011	0.2700271965947751
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.00361011	0.2700271965947751
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.00361011	0.2700271965947751
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00361011	0.2700271965947751
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00361011	0.2700271965947751
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.00361011	0.2700271965947751
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00361011	0.2700271965947751
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00361011	0.2700271965947751
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00361011	0.2700271965947751
WARBURG MICRO SYNDROME 3; WARBM3	0.00361011	0.2700271965947751
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00361011	0.2700271965947751
PHACE ASSOCIATION	0.00361011	0.2700271965947751
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00361011	0.2700271965947751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.00361011	0.2700271965947751
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.00361011	0.2700271965947751
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00361011	0.2700271965947751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00361011	0.2700271965947751
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.00361011	0.2700271965947751
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.00361011	0.2700271965947751
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00361011	0.2700271965947751
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00361011	0.2700271965947751
CHROMOSOME 19p13.13 DELETION SYNDROME	0.00361011	0.2700271965947751
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00361011	0.2700271965947751
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00361011	0.2700271965947751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00361011	0.2700271965947751
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00361011	0.2700271965947751
LAMB-SHAFFER SYNDROME	0.00361011	0.2700271965947751
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00361011	0.2700271965947751
PEHO SYNDROME; PEHO	0.00361011	0.2700271965947751
CRI-DU-CHAT SYNDROME	0.00361011	0.2700271965947751
METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY	0.00361011	0.2700271965947751
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.00361011	0.2700271965947751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00361011	0.2700271965947751
WARBURG MICRO SYNDROME 2; WARBM2	0.00361011	0.2700271965947751
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.00361011	0.2700271965947751
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.00361011	0.2700271965947751
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.00361011	0.2700271965947751
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00361011	0.2700271965947751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.00361011	0.2700271965947751
PEHO-LIKE SYNDROME; PEHOL	0.00361011	0.2700271965947751
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.00361011	0.2700271965947751
SPINOCEREBELLAR ATAXIA 1	0.00361011	0.2700271965947751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00361011	0.2700271965947751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00361011	0.2700271965947751
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.00361011	0.2700271965947751
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00361011	0.2700271965947751
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00361011	0.2700271965947751
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.00361011	0.2700271965947751
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.00361011	0.2700271965947751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00361011	0.2700271965947751
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00121359	0.09077349596423741
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00121359	0.09077349596423741
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00121359	0.09077349596423741
HYPERTELORISM, TEEBI TYPE; TBHS	0.00121359	0.09077349596423741
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00121359	0.09077349596423741
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00121359	0.09077349596423741
CROME SYNDROME	0.00121359	0.09077349596423741
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00121359	0.09077349596423741
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00121359	0.09077349596423741
#613986 PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	0.00121359	0.09077349596423741
OVARIAN DYSGENESIS 4; ODG4	0.00121359	0.09077349596423741
THREE M SYNDROME 2; 3M2	0.00121359	0.09077349596423741
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00121359	0.09077349596423741
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00121359	0.09077349596423741
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00121359	0.09077349596423741
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00121359	0.09077349596423741
22q11.2 distal deletion syndrome	0.00121359	0.09077349596423741
NOONAN SYNDROME 8; NS8	0.00121359	0.09077349596423741
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00121359	0.09077349596423741
MCDONOUGH SYNDROME	0.00121359	0.09077349596423741
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.00121359	0.09077349596423741
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00121359	0.09077349596423741
PFEIFFER-PALM-TELLER SYNDROME	0.00121359	0.09077349596423741
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00121359	0.09077349596423741
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.00121359	0.09077349596423741
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00121359	0.09077349596423741
SEPTOOPTIC DYSPLASIA	0.00121359	0.09077349596423741
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00121359	0.09077349596423741
245800 LAURENCE-MOON SYNDROME	0.00121359	0.09077349596423741
CHROMOSOME 2q37 DELETION SYNDROME	0.00121359	0.09077349596423741
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00121359	0.09077349596423741
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00121359	0.09077349596423741
OROFACIODIGITAL SYNDROME IX; OFD9	0.00121359	0.09077349596423741
AYME-GRIPP SYNDROME; AYGRP	0.00121359	0.09077349596423741
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00121359	0.09077349596423741
COFFIN-LOWRY SYNDROME; CLS	0.00121359	0.09077349596423741
MACS SYNDROME	0.00121359	0.09077349596423741
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00121359	0.09077349596423741
NIJMEGEN BREAKAGE SYNDROME	0.00121359	0.09077349596423741
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.00121359	0.09077349596423741
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00121359	0.09077349596423741
#307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	0.00121359	0.09077349596423741
BIEMOND SYNDROME II	0.00121359	0.09077349596423741
PERRAULT SYNDROME 3	0.00121359	0.09077349596423741
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00121359	0.09077349596423741
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00121359	0.09077349596423741
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.00121359	0.09077349596423741
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00121359	0.09077349596423741
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00121359	0.09077349596423741
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00121359	0.09077349596423741
LARSEN-LIKE SYNDROME	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00121359	0.09077349596423741
BRACHYDACTYLY, TYPE E2; BDE2	0.00121359	0.09077349596423741
STUVE-WIEDEMANN SYNDROME	0.00121359	0.09077349596423741
MASA SYNDROME	0.00121359	0.09077349596423741
POPOV-CHANG SYNDROME; POPCHAS	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00121359	0.09077349596423741
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00121359	0.09077349596423741
KBG SYNDROME	0.00121359	0.09077349596423741
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00121359	0.09077349596423741
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00121359	0.09077349596423741
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00121359	0.09077349596423741
CODAS SYNDROME	0.00121359	0.09077349596423741
CHROMOSOME 18P DELETION SYNDROME	0.00121359	0.09077349596423741
SACCHAROPINURIA	0.00121359	0.09077349596423741
PYGMY	0.00121359	0.09077349596423741
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00121359	0.09077349596423741
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.00121359	0.09077349596423741
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00121359	0.09077349596423741
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00121359	0.09077349596423741
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00121359	0.09077349596423741
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00121359	0.09077349596423741
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00121359	0.09077349596423741
EIKEN SYNDROME	0.00121359	0.09077349596423741
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00121359	0.09077349596423741
HYPOPHOSPHATASIA, CHILDHOOD	0.00121359	0.09077349596423741
608028 THAI SYMPHALANGISM SYNDROME	0.00121359	0.09077349596423741
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00121359	0.09077349596423741
MENKES DISEASE	0.00121359	0.09077349596423741
NOONAN SYNDROME 10; NS10	0.00121359	0.09077349596423741
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00121359	0.09077349596423741
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00121359	0.09077349596423741
CEREBELLOFACIODENTAL SYNDROME	0.00121359	0.09077349596423741
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00121359	0.09077349596423741
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00121359	0.09077349596423741
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00121359	0.09077349596423741
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.00121359	0.09077349596423741
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00121359	0.09077349596423741
OGDEN SYNDROME; OGDNS	0.00121359	0.09077349596423741
KENNERKNECHT SYNDROME	0.00121359	0.09077349596423741
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.00121359	0.09077349596423741
NOONAN SYNDROME 11; NS11	0.00121359	0.09077349596423741
MARINESCO-SJOGREN SYNDROME; MSS	0.00121359	0.09077349596423741
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00121359	0.09077349596423741
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00121359	0.09077349596423741
#612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB;;DWARFISM OF SINDH	0.00121359	0.09077349596423741
SAUL-WILSON SYNDROME; SWILS	0.00121359	0.09077349596423741
NAIL-PATELLA SYNDROME	0.00121359	0.09077349596423741
WIDOW&#39;S PEAK SYNDROME	0.00121359	0.09077349596423741
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00121359	0.09077349596423741
EXOSTOSES, MULTIPLE, TYPE I	0.00121359	0.09077349596423741
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.00121359	0.09077349596423741
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00121359	0.09077349596423741
FOUNTAIN SYNDROME	0.00121359	0.09077349596423741
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00121359	0.09077349596423741
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.00121359	0.09077349596423741
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00121359	0.09077349596423741
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00121359	0.09077349596423741
NOONAN SYNDROME 9; NS9	0.00121359	0.09077349596423741
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.00121359	0.09077349596423741
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00121359	0.09077349596423741
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00121359	0.09077349596423741
MARTSOLF SYNDROME	0.00121359	0.09077349596423741
SIFRIM-HITZ-WEISS SYNDROME	0.00121359	0.09077349596423741
MEIER-GORLIN SYNDROME 7	0.00121359	0.09077349596423741
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00121359	0.09077349596423741
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.00121359	0.09077349596423741
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00121359	0.09077349596423741
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00121359	0.09077349596423741
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.00121359	0.09077349596423741
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00121359	0.09077349596423741
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00121359	0.09077349596423741
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00121359	0.09077349596423741
THORACOPELVIC DYSOSTOSIS	0.00121359	0.09077349596423741
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00121359	0.09077349596423741
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00121359	0.09077349596423741
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00121359	0.09077349596423741
ATKIN-FLAITZ SYNDROME	0.00121359	0.09077349596423741
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00121359	0.09077349596423741
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.00121359	0.09077349596423741
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00121359	0.09077349596423741
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00121359	0.09077349596423741
VELOCARDIOFACIAL SYNDROME	0.00121359	0.09077349596423741
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00121359	0.09077349596423741
OSTEOGENESIS IMPERFECTA, TYPE X	0.00121359	0.09077349596423741
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.00121359	0.09077349596423741
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00121359	0.09077349596423741
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00121359	0.09077349596423741
SECKEL SYNDROME 2; SCKL2	0.00121359	0.09077349596423741
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00121359	0.09077349596423741
JOUBERT SYNDROME 26	0.00121359	0.09077349596423741
SATOYOSHI SYNDROME	0.00121359	0.09077349596423741
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.00121359	0.09077349596423741
RUIJS-AALFS SYNDROME; RJALS	0.00121359	0.09077349596423741
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00121359	0.09077349596423741
GLASS SYNDROME	0.00121359	0.09077349596423741
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.00121359	0.09077349596423741
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00121359	0.09077349596423741
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00121359	0.09077349596423741
SECKEL SYNDROME 5; SCKL5	0.00121359	0.09077349596423741
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00121359	0.09077349596423741
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00121359	0.09077349596423741
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.00121359	0.09077349596423741
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00121359	0.09077349596423741
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00121359	0.09077349596423741
MICROHYDRANENCEPHALY; MHAC	0.00121359	0.09077349596423741
#614728 SECKEL SYNDROME 6; SCKL6	0.00121359	0.09077349596423741
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00121359	0.09077349596423741
GURRIERI SYNDROME	0.00121359	0.09077349596423741
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00121359	0.09077349596423741
HUNTER-MACDONALD SYNDROME	0.00121359	0.09077349596423741
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00121359	0.09077349596423741
Aarskog-Scott syndrome	0.00121359	0.09077349596423741
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.00121359	0.09077349596423741
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00121359	0.09077349596423741
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00121359	0.09077349596423741
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00121359	0.09077349596423741
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00121359	0.09077349596423741
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00121359	0.09077349596423741
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00121359	0.09077349596423741
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00121359	0.09077349596423741
Williams-Beuren Syndrome (WBS)	0.00121359	0.09077349596423741
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00121359	0.09077349596423741
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00121359	0.09077349596423741
CHROMOSOME 1p35 DELETION SYNDROME	0.00121359	0.09077349596423741
FORSYTHE-WAKELING SYNDROME; FWS	0.00121359	0.09077349596423741
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00121359	0.09077349596423741
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00121359	0.09077349596423741
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00121359	0.09077349596423741
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00121359	0.09077349596423741
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00121359	0.09077349596423741
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00121359	0.09077349596423741
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00121359	0.09077349596423741
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00121359	0.09077349596423741
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00121359	0.09077349596423741
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00121359	0.09077349596423741
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00121359	0.09077349596423741
NASODIGITOACOUSTIC SYNDROME	0.00121359	0.09077349596423741
SECKEL SYNDROME 8; SCKL8	0.00121359	0.09077349596423741
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00121359	0.09077349596423741
BRACHYDACTYLY, TYPE A6	0.00121359	0.09077349596423741
LOEYS-DIETZ SYNDROME 5	0.00121359	0.09077349596423741
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00121359	0.09077349596423741
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00121359	0.09077349596423741
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00121359	0.09077349596423741
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00121359	0.09077349596423741
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00121359	0.09077349596423741
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00121359	0.09077349596423741
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00121359	0.09077349596423741
SJOGREN-LARSSON SYNDROME; SLS	0.00121359	0.09077349596423741
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00121359	0.09077349596423741
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00121359	0.09077349596423741
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00121359	0.09077349596423741
Pierpont syndrome	0.00121359	0.09077349596423741
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00121359	0.09077349596423741
CHROMOSOME 15q25 DELETION SYNDROME	0.00121359	0.09077349596423741
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.00121359	0.09077349596423741
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00121359	0.09077349596423741
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.00121359	0.09077349596423741
AROMATASE EXCESS SYNDROME	0.00121359	0.09077349596423741
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00121359	0.09077349596423741
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00121359	0.09077349596423741
Potocki-Lupski syndrome (17p11.2 duplication syndrome)	0.00121359	0.09077349596423741
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00121359	0.09077349596423741
PROPIONIC ACIDEMIA	0.00121359	0.09077349596423741
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.00121359	0.09077349596423741
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00121359	0.09077349596423741
Smith-Magenis Syndrome	0.00121359	0.09077349596423741
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00121359	0.09077349596423741
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00121359	0.09077349596423741
NEUROFIBROMATOSIS, TYPE I	0.00121359	0.09077349596423741
DYSTONIA 28, CHILDHOOD-ONSET	0.00121359	0.09077349596423741
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00121359	0.09077349596423741
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.00121359	0.09077349596423741
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00121359	0.09077349596423741
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00121359	0.09077349596423741
ASPARTYLGLUCOSAMINURIA; AGU	0.00121359	0.09077349596423741
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00121359	0.09077349596423741
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00121359	0.09077349596423741
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00121359	0.09077349596423741
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00121359	0.09077349596423741
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.00121359	0.09077349596423741
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00121359	0.09077349596423741
#150250 LARSEN SYNDROME; LRS	0.00121359	0.09077349596423741
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00121359	0.09077349596423741
OROFACIODIGITAL SYNDROME I; OFD1	0.00121359	0.09077349596423741
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	0.00121359	0.09077349596423741
CRANIOFRONTONASAL SYNDROME; CFNS	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00121359	0.09077349596423741
JOHANSON-BLIZZARD SYNDROME; JBS	0.00121359	0.09077349596423741
SPONDYLOPERIPHERAL DYSPLASIA	0.00121359	0.09077349596423741
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00121359	0.09077349596423741
AURICULOOSTEODYSPLASIA	0.00121359	0.09077349596423741
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00121359	0.09077349596423741
C SYNDROME	0.00121359	0.09077349596423741
COFFIN-SIRIS SYNDROME 6; CSS6	0.00121359	0.09077349596423741
DIAMOND-BLACKFAN ANEMIA 4	0.00121359	0.09077349596423741
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00121359	0.09077349596423741
#300555 DENT DISEASE 2	0.00121359	0.09077349596423741
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00121359	0.09077349596423741
N-ACETYLASPARTATE DEFICIENCY; NACED	0.00121359	0.09077349596423741
HOLOPROSENCEPHALY 1; HPE1	0.00121359	0.09077349596423741
GRACILE BONE DYSPLASIA; GCLEB	0.00121359	0.09077349596423741
MICROPHTHALMIA, SYNDROMIC 3	0.00121359	0.09077349596423741
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00121359	0.09077349596423741
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00121359	0.09077349596423741
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00121359	0.09077349596423741
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00121359	0.09077349596423741
CRANIOECTODERMAL DYSPLASIA 4	0.00121359	0.09077349596423741
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00121359	0.09077349596423741
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00121359	0.09077349596423741
GLYCOGEN STORAGE DISEASE IA	0.00121359	0.09077349596423741
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00121359	0.09077349596423741
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00121359	0.09077349596423741
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.00121359	0.09077349596423741
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00121359	0.09077349596423741
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00121359	0.09077349596423741
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00121359	0.09077349596423741
FONTAINE PROGEROID SYNDROME; FPS	0.00121359	0.09077349596423741
WEILL-MARCHESANI SYNDROME 3	0.00121359	0.09077349596423741
CHROMOSOME 17q12 DELETION SYNDROME	0.00121359	0.09077349596423741
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00121359	0.09077349596423741
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00121359	0.09077349596423741
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00121359	0.09077349596423741
EXOSTOSES, MULTIPLE, TYPE II	0.00121359	0.09077349596423741
MIRAGE SYNDROME; MIRAGE	0.00121359	0.09077349596423741
WERNER SYNDROME; WRN	0.00121359	0.09077349596423741
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00121359	0.09077349596423741
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.00121359	0.09077349596423741
CHARGE-LIKE SYNDROME, X-LINKED	0.00121359	0.09077349596423741
LESCH-NYHAN SYNDROME; LNS	0.00121359	0.09077349596423741
SPINAL DYSPLASIA, ANHALT TYPE	0.00121359	0.09077349596423741
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00121359	0.09077349596423741
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00121359	0.09077349596423741
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00121359	0.09077349596423741
FRIAS SYNDROME	0.00121359	0.09077349596423741
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00121359	0.09077349596423741
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00121359	0.09077349596423741
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00121359	0.09077349596423741
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00121359	0.09077349596423741
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00121359	0.09077349596423741
SPASTIC PARAPARESIS AND DEAFNESS	0.00121359	0.09077349596423741
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00121359	0.09077349596423741
SHPRINTZEN OMPHALOCELE SYNDROME	0.00121359	0.09077349596423741
COFFIN-SIRIS SYNDROME 5	0.00121359	0.09077349596423741
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00121359	0.09077349596423741
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00121359	0.09077349596423741
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00121359	0.09077349596423741
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00121359	0.09077349596423741
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00121359	0.09077349596423741
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00121359	0.09077349596423741
Myhre syndrome	0.00121359	0.09077349596423741
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00121359	0.09077349596423741
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.00121359	0.09077349596423741
#612649 CILIARY DYSKINESIA, PRIMARY, 11; CILD11	0.00121359	0.09077349596423741
IMMUNODEFICIENCY 55; IMD55	0.00121359	0.09077349596423741
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00121359	0.09077349596423741
#612650 CILIARY DYSKINESIA, PRIMARY, 12; CILD12	0.00121359	0.09077349596423741
GLYCOGEN STORAGE DISEASE IB	0.00121359	0.09077349596423741
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00121359	0.09077349596423741
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00121359	0.09077349596423741
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.00121359	0.09077349596423741
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00121359	0.09077349596423741
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00121359	0.09077349596423741
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00121359	0.09077349596423741
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00121359	0.09077349596423741
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00121359	0.09077349596423741
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00121359	0.09077349596423741
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00121359	0.09077349596423741
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00121359	0.09077349596423741
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00121359	0.09077349596423741
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00121359	0.09077349596423741
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.00121359	0.09077349596423741
STEEL SYNDROME; STLS	0.00121359	0.09077349596423741
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00121359	0.09077349596423741
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00121359	0.09077349596423741
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.00121359	0.09077349596423741
OROFACIODIGITAL SYNDROME IV; OFD4	0.00121359	0.09077349596423741
HAIRY ELBOWS	0.00121359	0.09077349596423741
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00121359	0.09077349596423741
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00121359	0.09077349596423741
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00121359	0.09077349596423741
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00121359	0.09077349596423741
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00121359	0.09077349596423741
#154780 MARSHALL SYNDROME; MRSHS	0.00121359	0.09077349596423741
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.00121359	0.09077349596423741
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00121359	0.09077349596423741
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00121359	0.09077349596423741
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00121359	0.09077349596423741
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00121359	0.09077349596423741
ANAUXETIC DYSPLASIA 2; ANXD2	0.00121359	0.09077349596423741
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00121359	0.09077349596423741
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00121359	0.09077349596423741
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00121359	0.09077349596423741
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00121359	0.09077349596423741
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.00121359	0.09077349596423741
SECKEL SYNDROME 4	0.00121359	0.09077349596423741
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00121359	0.09077349596423741
KABUKI SYNDROME 1	0.00121359	0.09077349596423741
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00121359	0.09077349596423741
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00121359	0.09077349596423741
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00121359	0.09077349596423741
CRANIOECTODERMAL DYSPLASIA 3	0.00121359	0.09077349596423741
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00121359	0.09077349596423741
LUSCAN-LUMISH SYNDROME; LLS	0.00121359	0.09077349596423741
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00121359	0.09077349596423741
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00121359	0.09077349596423741
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.00121359	0.09077349596423741
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.00121359	0.09077349596423741
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00121359	0.09077349596423741
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00121359	0.09077349596423741
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00121359	0.09077349596423741
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00121359	0.09077349596423741
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00121359	0.09077349596423741
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.00121359	0.09077349596423741
MUCOLIPIDOSIS III GAMMA	0.00121359	0.09077349596423741
DENT DISEASE 1	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00121359	0.09077349596423741
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00121359	0.09077349596423741
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00121359	0.09077349596423741
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00121359	0.09077349596423741
HADZISELIMOVIC SYNDROME	0.00121359	0.09077349596423741
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00121359	0.09077349596423741
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00121359	0.09077349596423741
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00121359	0.09077349596423741
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00121359	0.09077349596423741
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00121359	0.09077349596423741
OROFACIODIGITAL SYNDROME VI	0.00121359	0.09077349596423741
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00121359	0.09077349596423741
NOONAN SYNDROME 7; NS7	0.00121359	0.09077349596423741
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00121359	0.09077349596423741
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00121359	0.09077349596423741
KEARNS-SAYRE SYNDROME; KSS	0.00121359	0.09077349596423741
RADIAL-RENAL SYNDROME	0.00121359	0.09077349596423741
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00121359	0.09077349596423741
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.00121359	0.09077349596423741
RUVALCABA SYNDROME	0.00121359	0.09077349596423741
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00121359	0.09077349596423741
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.00121359	0.09077349596423741
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00121359	0.09077349596423741
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00121359	0.09077349596423741
LEGG-CALVE-PERTHES DISEASE	0.00121359	0.09077349596423741
CHITAYAT SYNDROME	0.00121359	0.09077349596423741
SONODA SYNDROME	0.00121359	0.09077349596423741
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00121359	0.09077349596423741
#604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	0.00121359	0.09077349596423741
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00121359	0.09077349596423741
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00121359	0.09077349596423741
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00121359	0.09077349596423741
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00121359	0.09077349596423741
THUMB DEFORMITY AND ALOPECIA	0.00121359	0.09077349596423741
DIAMOND-BLACKFAN ANEMIA 10	0.00121359	0.09077349596423741
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00121359	0.09077349596423741
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00121359	0.09077349596423741
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.00121359	0.09077349596423741
NOONAN SYNDROME 2; NS2	0.00121359	0.09077349596423741
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00121359	0.09077349596423741
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00121359	0.09077349596423741
STICKLER SYNDROME, TYPE V; STL5	0.00121359	0.09077349596423741
Rothmund-Thomson syndrome	0.00121359	0.09077349596423741
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00121359	0.09077349596423741
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00121359	0.09077349596423741
RETT SYNDROME; RTT	0.00121359	0.09077349596423741
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.00121359	0.09077349596423741
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00121359	0.09077349596423741
STIFF SKIN SYNDROME	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED 92	0.00121359	0.09077349596423741
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00121359	0.09077349596423741
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00121359	0.09077349596423741
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.00121359	0.09077349596423741
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00121359	0.09077349596423741
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00121359	0.09077349596423741
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00121359	0.09077349596423741
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00121359	0.09077349596423741
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00121359	0.09077349596423741
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00121359	0.09077349596423741
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00121359	0.09077349596423741
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.00121359	0.09077349596423741
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00121359	0.09077349596423741
FEINGOLD SYNDROME 2; FGLDS2	0.00121359	0.09077349596423741
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00121359	0.09077349596423741
PRECOCIOUS PUBERTY, CENTRAL	0.00121359	0.09077349596423741
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00121359	0.09077349596423741
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00121359	0.09077349596423741
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00121359	0.09077349596423741
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00121359	0.09077349596423741
RAINE SYNDROME	0.00121359	0.09077349596423741
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00121359	0.09077349596423741
SAY SYNDROME	0.00121359	0.09077349596423741
HARTNUP DISORDER	0.00121359	0.09077349596423741
ACROCRANIOFACIAL DYSOSTOSIS	0.00121359	0.09077349596423741
#226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;;EBS-MD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS	0.00121359	0.09077349596423741
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00121359	0.09077349596423741
2q33.1 deletion syndrome	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00121359	0.09077349596423741
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00121359	0.09077349596423741
ALAZAMI-YUAN SYNDROME	0.00121359	0.09077349596423741
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00121359	0.09077349596423741
CULLER-JONES SYNDROME; CJS	0.00121359	0.09077349596423741
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00121359	0.09077349596423741
CORNELIA DE LANGE SYNDROME 3	0.00121359	0.09077349596423741
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00121359	0.09077349596423741
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00121359	0.09077349596423741
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00121359	0.09077349596423741
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00121359	0.09077349596423741
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00121359	0.09077349596423741
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED 99	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00121359	0.09077349596423741
PELVIS-SHOULDER DYSPLASIA	0.00121359	0.09077349596423741
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00121359	0.09077349596423741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00121359	0.09077349596423741
OVARIAN DYSGENESIS 5; ODG5	0.00121359	0.09077349596423741
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00121359	0.09077349596423741
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED 2	0.00121359	0.09077349596423741
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00121359	0.09077349596423741
15q24 recurrent microdeletion syndrome	0.00121359	0.09077349596423741
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00121359	0.09077349596423741
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00121359	0.09077349596423741
LISSENCEPHALY 4	0.00121359	0.09077349596423741
OHDO SYNDROME	0.00121359	0.09077349596423741
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00121359	0.09077349596423741
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00121359	0.09077349596423741
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00121359	0.09077349596423741
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00121359	0.09077349596423741
600736 VELOFACIOSKELETAL SYNDROME	0.00121359	0.09077349596423741
3MC SYNDROME 3	0.00121359	0.09077349596423741
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00121359	0.09077349596423741
260150 PALANT CLEFT PALATE SYNDROME	0.00121359	0.09077349596423741
#611554 LEOPARD SYNDROME 2	0.00121359	0.09077349596423741
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00121359	0.09077349596423741
BRUCK SYNDROME 2	0.00121359	0.09077349596423741
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00121359	0.09077349596423741
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.00121359	0.09077349596423741
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00121359	0.09077349596423741
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00121359	0.09077349596423741
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00121359	0.09077349596423741
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00121359	0.09077349596423741
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00121359	0.09077349596423741
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00121359	0.09077349596423741
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00121359	0.09077349596423741
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00121359	0.09077349596423741
#278250 WRINKLY SKIN SYNDROME; WSS	0.00121359	0.09077349596423741
PRIMROSE SYNDROME; PRIMS	0.00121359	0.09077349596423741
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00121359	0.09077349596423741
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00121359	0.09077349596423741
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00121359	0.09077349596423741
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00121359	0.09077349596423741
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00121359	0.09077349596423741
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00121359	0.09077349596423741
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00121359	0.09077349596423741
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00121359	0.09077349596423741
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00121359	0.09077349596423741
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00121359	0.09077349596423741
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00121359	0.09077349596423741
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00121359	0.09077349596423741
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00121359	0.09077349596423741
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00121359	0.09077349596423741
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00121359	0.09077349596423741
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00121359	0.09077349596423741
NOONAN SYNDROME 3; NS3	0.00121359	0.09077349596423741
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00121359	0.09077349596423741
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00121359	0.09077349596423741
MEND SYNDROME; MEND	0.00121359	0.09077349596423741
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00121359	0.09077349596423741
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.00121359	0.09077349596423741
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00121359	0.09077349596423741
HYPOPHOSPHATEMIC BONE DISEASE	0.00121359	0.09077349596423741
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00121359	0.09077349596423741
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00121359	0.09077349596423741
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	0.00121359	0.09077349596423741
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00121359	0.09077349596423741
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00121359	0.09077349596423741
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00121359	0.09077349596423741
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00121359	0.09077349596423741
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00121359	0.09077349596423741
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00121359	0.09077349596423741
#300867 KABUKI SYNDROME 2; KABUK2	0.00121359	0.09077349596423741
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00121359	0.09077349596423741
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00121359	0.09077349596423741
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00121359	0.09077349596423741
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED 45	0.00121359	0.09077349596423741
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00121359	0.09077349596423741
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00121359	0.09077349596423741
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00121359	0.09077349596423741
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00121359	0.09077349596423741
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00121359	0.09077349596423741
#300582 SHORT STATURE, IDIOPATHIC, X-LINKED; ISS	0.00121359	0.09077349596423741
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00121359	0.09077349596423741
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00121359	0.09077349596423741
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00121359	0.09077349596423741
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.00121359	0.09077349596423741
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.00121359	0.09077349596423741
XQ25 DUPLICATION SYNDROME	0.00121359	0.09077349596423741
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00121359	0.09077349596423741
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00121359	0.09077349596423741
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED 84	0.00121359	0.09077349596423741
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.00121359	0.09077349596423741
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00121359	0.09077349596423741
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00121359	0.09077349596423741
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.00121359	0.09077349596423741
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00121359	0.09077349596423741
Mental retardation, autosomal dominant 21	0.00121359	0.09077349596423741
TEEBI-SHALTOUT SYNDROME; TBSH	0.00121359	0.09077349596423741
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00121359	0.09077349596423741
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.00121359	0.09077349596423741
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00121359	0.09077349596423741
#259450 BRUCK SYNDROME 1; BRKS1	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.00121359	0.09077349596423741
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.00121359	0.09077349596423741
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00121359	0.09077349596423741
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00121359	0.09077349596423741
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00121359	0.09077349596423741
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00121359	0.09077349596423741
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00121359	0.09077349596423741
RAPADILINO SYNDROME	0.00121359	0.09077349596423741
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00121359	0.09077349596423741
RAMON SYNDROME	0.00121359	0.09077349596423741
FANCONI ANEMIA	0.00121359	0.09077349596423741
NOONAN SYNDROME 6; NS6	0.00121359	0.09077349596423741
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00121359	0.09077349596423741
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00121359	0.09077349596423741
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00121359	0.09077349596423741
OCULOPALATOCEREBRAL SYNDROME	0.00121359	0.09077349596423741
PALLISTER-HALL SYNDROME	0.00121359	0.09077349596423741
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00121359	0.09077349596423741
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.00121359	0.09077349596423741
EHLERS-DANLOS SYNDROME, TYPE I	0.00121359	0.09077349596423741
CHROMOSOME 10Q26 DELETION SYNDROME	0.00121359	0.09077349596423741
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00121359	0.09077349596423741
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00121359	0.09077349596423741
SCHAAF-YANG SYNDROME; SHFYNG	0.00121359	0.09077349596423741
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.00121359	0.09077349596423741
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.00121359	0.09077349596423741
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00121359	0.09077349596423741
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00121359	0.09077349596423741
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00121359	0.09077349596423741
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00121359	0.09077349596423741
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00121359	0.09077349596423741
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00121359	0.09077349596423741
#276880 UROCANASE DEFICIENCY	0.00121359	0.09077349596423741
AL KAISSI SYNDROME; ALKAS	0.00121359	0.09077349596423741
LATERAL MENINGOCELE SYNDROME	0.00121359	0.09077349596423741
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00121359	0.09077349596423741
COFFIN-SIRIS SYNDROME 7; CSS7	0.00121359	0.09077349596423741
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00121359	0.09077349596423741
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00121359	0.09077349596423741
PRADER-WILLI SYNDROME; PWS	0.00121359	0.09077349596423741
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00121359	0.09077349596423741
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00121359	0.09077349596423741
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00121359	0.09077349596423741
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00121359	0.09077349596423741
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.00121359	0.09077349596423741
DIAMOND-BLACKFAN ANEMIA 8	0.00121359	0.09077349596423741
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00121359	0.09077349596423741
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00121359	0.09077349596423741
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00121359	0.09077349596423741
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00121359	0.09077349596423741
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.00121359	0.09077349596423741
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00121359	0.09077349596423741
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00121359	0.09077349596423741
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00121359	0.09077349596423741
WIEACKER-WOLFF SYNDROME	0.00121359	0.09077349596423741
COXOAURICULAR SYNDROME	0.00121359	0.09077349596423741
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00121359	0.09077349596423741
SCHIZOPHRENIA 1; SCZD1	0.00121359	0.09077349596423741
#613707 LEOPARD SYNDROME 3; LPRD3	0.00121359	0.09077349596423741
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.00121359	0.09077349596423741
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00121359	0.09077349596423741
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00121359	0.09077349596423741
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00121359	0.09077349596423741
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00121359	0.09077349596423741
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00121359	0.09077349596423741
Cat-Eye Syndrome (Type I)	0.00121359	0.09077349596423741
Orofaciodigital syndrome XVII	0.00121359	0.09077349596423741
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00121359	0.09077349596423741
Trichothiodystrophy 5, nonphotosensitive	0.00121359	0.09077349596423741
MUCOLIPIDOSIS III ALPHA/BETA	0.00121359	0.09077349596423741
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00121359	0.09077349596423741
FLOATING-HARBOR SYNDROME	0.00121359	0.09077349596423741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00121359	0.09077349596423741
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00121359	0.09077349596423741
NOONAN SYNDROME 5; NS5	0.00121359	0.09077349596423741
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00121359	0.09077349596423741
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00121359	0.09077349596423741
RHYNS SYNDROME; RHYNS	0.00121359	0.09077349596423741
NOONAN SYNDROME 4; NS4	0.00121359	0.09077349596423741
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00121359	0.09077349596423741
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00121359	0.09077349596423741
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00121359	0.09077349596423741
DIAMOND-BLACKFAN ANEMIA 5	0.00121359	0.09077349596423741
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00121359	0.09077349596423741
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00121359	0.09077349596423741
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00121359	0.09077349596423741
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00121359	0.09077349596423741
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00121359	0.09077349596423741
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00121359	0.09077349596423741
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00121359	0.09077349596423741
KOOLEN-DE VRIES SYNDROME; KDVS	0.00121359	0.09077349596423741
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00121359	0.09077349596423741
STORMORKEN SYNDROME; STRMK	0.00121359	0.09077349596423741
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00121359	0.09077349596423741
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00121359	0.09077349596423741
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00121359	0.09077349596423741
GLYCOGEN STORAGE DISEASE IXB	0.00121359	0.09077349596423741
GLYCEROL KINASE DEFICIENCY; GKD	0.00121359	0.09077349596423741
